1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Strategy

Perrigo Plays Customary Card For Approval Of First OTC Ibuprofen-Acetaminophen Generic In US

 
• By Bob Kronemyer

First generic of Haleon Advil Dual Action approved as brand lost three-year market exclusivity and day after Perrigo announced end of phase 1 of turnaround strategy and start of starting phase 2.

• Source: Shutterstock

As Perrigo Company PLC looks ahead in its transformation, it leverages its traditional strength of being first to launch generics of OTC brands for its latest portfolio expansion.

The Dublin-based firm on 1 March announced approval from the US Food and Drug Administration for OTC 125-mg ibuprofen and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

People On The Move: Appointments At AESGP, PGEU, Nicapur

 
• By Tom Gallen

A round-up of the latest European health & wellness appointments: Workman re-elected AESGP chair; PGEU names 2026 leadership; Nicapur gets managing director.

Germany’s PharmaSGP To Be Taken Private

 
• By Tom Gallen

Consumer health player PharmaSGP will be taken private by its biggest shareholder, FUTRUE.

People On The Move: Appointments At Klosterfrau, Haleon, Opella

 
• By Tom Gallen

A round-up of the latest consumer health industry appointments: Kloserfrau makes changes to management in Germany; Haleon hires Pakistan head; Opella names Americas leader.

Stada Held Back By Weak Cough & Cold Season

 
• By Tom Gallen

While sales of seasonal products struggled during Q1, Stada pointed to the continuing strength of its underlying Consumer Healthcare portfolio.

More from Business

US Consumer Health, Beauty Sectors: Expecting Tariff Policy Changes, Buckling Up For The Ride

 
• By Malcolm Spicer

As firms in OTC drug, dietary supplement and personal care/beauty sectors reported results for January-March period after Trump announced reciprocal tariffs, they buckled up for more changes in the president’s thinking likely to affect consumer spending as well as their costs.

Galenica’s Verfora Gets Off To Flying Start In Swiss CHC Market

 
• By Tom Gallen

Verfora grows almost 10-times faster than the Swiss consumer health market in the opening months of 2025.

People On The Move: Appointments at Hermes, Assosalute, Moberg

 
• By Tom Gallen

A round up of the latest European consumer health exec moves: Hermes hires management board chair; Assosalute elects directors; Moberg appoints ex-Orkla Health CEO.